Sandra Lehrman Joins Panacos Pharmaceuticals Board of Directors.(Brief Article)

2002 FEB 6 - (NewsRx.com & NewsRx.net) -- Panacos Pharmaceuticals has appointed Sandra Nusinoff Lehrman, MD, to its board of directors. Lehrman has more than 18 years of experience in senior executive management within the pharmaceutical and biotechnology industries, most recently as president and chief executive officer of Genzyme Transgenics Corp., a publicly traded biotech company.

Lehrman began her career as a physician scientist specializing in pediatric infectious diseases, then joined Burroughs Wellcome Corp. in 1983 and spent the next 12 years in positions of increasing responsibility at that company. During this time she gained substantial expertise in antiviral drug development. As vice president, infectious diseases, immunology and biotechnology, she played a pivotal role in the development of the first approved anti-HIV drug, AZT, through preclinical and clinical testing to marketing approval.

In 1995 Lehrman joined Triangle Pharmaceuticals ...